Ionis Pharmaceuticals Shares Outstanding 2006-2018 | IONS

Ionis Pharmaceuticals shares outstanding history from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Ionis Pharmaceuticals shares outstanding for the quarter ending September 30, 2018 were 0.143B, a 15.23% increase year-over-year.
  • Ionis Pharmaceuticals 2017 shares outstanding were 0.126B, a 4.27% increase from 2016.
  • Ionis Pharmaceuticals 2016 shares outstanding were 0.121B, a 1.01% increase from 2015.
  • Ionis Pharmaceuticals 2015 shares outstanding were 0.12B, a 1.72% increase from 2014.
Ionis Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2017 126
2016 121
2015 120
2014 118
2013 111
2012 101
2011 100
2010 99
2009 98
2008 95
2007 84
2006 74
2005 63
Ionis Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 143
Q2 2018 129
Q1 2018 125
Q4 2017 126
Q3 2017 124
Q2 2017 124
Q1 2017 125
Q4 2016 121
Q3 2016 123
Q2 2016 121
Q1 2016 121
Q4 2015 120
Q3 2015 120
Q2 2015 128
Q1 2015 119
Q4 2014 118
Q3 2014 118
Q2 2014 118
Q1 2014 117
Q4 2013 111
Q3 2013 115
Q2 2013 109
Q1 2013 102
Q4 2012 101
Q3 2012 101
Q2 2012 100
Q1 2012 100
Q4 2011 100
Q3 2011 100
Q2 2011 100
Q1 2011 100
Q4 2010 99
Q3 2010 99
Q2 2010 99
Q1 2010 99
Q4 2009 98
Q3 2009 98
Q2 2009 98
Q1 2009 98
Q4 2008 95
Q3 2008 100
Q2 2008 95
Q1 2008 91
Q4 2007 84
Q3 2007 84
Q2 2007 83
Q1 2007 82
Q4 2006 74
Q3 2006 74
Q2 2006 73
Q1 2006 72
Q4 2005 63
Q3 2005 64
Q2 2005 58
Q1 2005 58
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.136B $0.508B
Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.922B 11.07
Zoetis (ZTS) United States $40.810B 27.94
Grifols (GRFS) Spain $12.660B 15.45
Jazz Pharmaceuticals (JAZZ) Ireland $8.354B 11.99
Neurocrine Biosciences (NBIX) United States $6.508B 1435.40
Tilray (TLRY) United States $6.139B 0.00
Nektar Therapeutics (NKTR) United States $5.913B 8.48
Catalent (CTLT) United States $4.978B 20.88
Impax Laboratories (AMRX) United States $4.840B 25.73
Sage Therapeutics (SAGE) United States $4.751B 0.00
United Therapeutics (UTHR) United States $4.646B 7.60
Loxo Oncology (LOXO) United States $4.148B 0.00
TESARO (TSRO) United States $4.055B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.391B 12.56
FibroGen (FGEN) United States $3.313B 0.00
USANA Health Sciences (USNA) United States $2.807B 23.89
Endo (ENDP) Ireland $2.118B 3.24
Xencor (XNCR) United States $1.984B 0.00
Endocyte (ECYT) United States $1.967B 0.00
Heron Therapeutics (HRTX) United States $1.946B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.850B 250.00
Corcept Therapeutics (CORT) United States $1.779B 26.12
Ironwood Pharmaceuticals (IRWD) United States $1.761B 0.00
Aerie Pharmaceuticals (AERI) United States $1.687B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.686B 0.00
Zogenix (ZGNX) United States $1.671B 0.00
PTC Therapeutics (PTCT) United States $1.626B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.430B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.398B 19.66
Tricida (TCDA) United States $1.296B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.287B 0.00
Esperion Therapeutics (ESPR) United States $1.241B 0.00
Portola Pharmaceuticals (PTLA) United States $1.225B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.187B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.883B 0.00
TherapeuticsMD (TXMD) United States $0.856B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.789B 0.00
ImmunoGen (IMGN) United States $0.772B 0.00
Radius Health (RDUS) United States $0.697B 0.00
Forty Seven (FTSV) United States $0.656B 0.00
Collegium Pharmaceutical (COLL) United States $0.597B 0.00
Karyopharm Therapeutics (KPTI) United States $0.577B 0.00
Siga Technologies (SIGA) United States $0.556B 0.00
ChemoCentryx (CCXI) United States $0.505B 39.96
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.492B 0.00
Flexion Therapeutics (FLXN) United States $0.488B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.465B 27.40
Rigel Pharmaceuticals (RIGL) United States $0.450B 0.00
GlycoMimetics (GLYC) United States $0.444B 0.00
Xeris Pharmaceuticals (XERS) United States $0.417B 0.00
Dermira (DERM) United States $0.413B 0.00
CASI Pharmaceuticals (CASI) United States $0.411B 0.00
Akebia Therapeutics (AKBA) United States $0.403B 0.00
Odonate Therapeutics (ODT) United States $0.396B 0.00
Translate Bio (TBIO) United States $0.377B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.360B 0.00
ArQule (ARQL) United States $0.360B 0.00
KalVista Pharmaceuticals (KALV) United States $0.347B 0.00
Tyme Technologies (TYME) United States $0.334B 0.00
Concert Pharmaceuticals (CNCE) United States $0.320B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.320B 0.00
OptiNose (OPTN) United States $0.311B 0.00
Majesco Entertainment (PTE) United States $0.310B 0.00
Aratana Therapeutics (PETX) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.287B 0.00
Minerva Neurosciences (NERV) United States $0.285B 0.00
Tapimmune (MRKR) United States $0.276B 0.00
Dova Pharmaceuticals (DOVA) United States $0.254B 0.00
Depomed (ASRT) United States $0.251B 9.36
Mast Therapeutics (SVRA) United States $0.249B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.247B 0.00
IMV INC (IMV) Canada $0.241B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.240B 0.00
Aldeyra Therapeutics (ALDX) United States $0.231B 0.00
Ocular Therapeutix (OCUL) United States $0.207B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.205B 0.00
Galectin Therapeutics (GALT) United States $0.203B 0.00
Affimed (AFMD) Germany $0.201B 0.00
Zafgen (ZFGN) United States $0.201B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.188B 0.00
Aquestive Therapeutics (AQST) United States $0.182B 0.00
Lannett Co Inc (LCI) United States $0.179B 1.55
Opexa Therapeutics (ACER) United States $0.170B 0.00
Calithera Biosciences (CALA) United States $0.167B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.167B 0.00
MEI Pharma (MEIP) United States $0.166B 0.00
Molecular Templates (MTEM) United States $0.165B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.165B 0.00
ContraFect (CFRX) United States $0.157B 0.00
Nature's Sunshine Products (NATR) United States $0.154B 0.00
Neon Therapeutics (NTGN) United States $0.152B 0.00
Recro Pharma (REPH) United States $0.149B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.142B 0.00
ElectroCore (ECOR) United States $0.141B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.140B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.136B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.130B 0.00
MediWound (MDWD) Israel $0.128B 0.00
Cardiome Pharma (CORV) Canada $0.124B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.123B 0.00
Ardelyx (ARDX) United States $0.119B 0.00
Adherex Technologies (FENC) United States $0.115B 0.00
Jounce Therapeutics (JNCE) United States $0.112B 0.00
DURECT (DRRX) United States $0.108B 0.00
Champions Oncology (CSBR) United States $0.107B 0.00
Rafael Holdings (RFL) United States $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.104B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 0.00
ProNAi Therapeutics (SRRA) Canada $0.094B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.084B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.079B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.079B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.074B 7.31
CTI BioPharma (CTIC) United States $0.071B 0.00
Achaogen (AKAO) United States $0.071B 0.00
Immune Design (IMDZ) United States $0.070B 0.00
Melinta Therapeutics (MLNT) United States $0.069B 0.00
Infinity Pharmaceuticals (INFI) United States $0.067B 0.00
Otonomy (OTIC) United States $0.067B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
BioLineRx (BLRX) Israel $0.065B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.059B 36.63
Neos Therapeutics (NEOS) United States $0.058B 0.00
KemPharm (KMPH) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.055B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.047B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.045B 0.00
Genocea Biosciences (GNCA) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.037B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.03
Capnia (SLNO) United States $0.034B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.028B 0.00
Novan (NOVN) United States $0.028B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.027B 0.00
IsoRay (ISR) United States $0.027B 0.00
Trillium Therapeutics (TRIL) Canada $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.024B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.024B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Biomerica (BMRA) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
SCYNEXIS (SCYX) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
PharmAthene (ALT) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Citius Pharmaceuticals (CTXR) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.017B 6.30
Aviragen Therapeutics (VXRT) United States $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Onconova Therapeutics (ONTX) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.015B 0.00
Shineco (TYHT) China $0.013B 1.45
Regulus Therapeutics (RGLS) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Aradigm (ARDM) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00